Company Categories: Antibodies, Antigens, CDMO, Drug Development, Drug Discovery, Enzymes, Fine & Specialty Chemicals, Peptides and Recombinant Proteins
R&D Products and Custom Chemicals, Peptides and Key Biologics
DetailsBiosynth is a global leader in the manufacture and supply of fine & complex chemicals, peptides, and key biologics including enzymes and antibodies to service the needs of pharma, biotech, research, diagnostic and chemistry businesses around the world.
With cutting-edge laboratories and modern manufacturing plants across Europe, America and Asia, underpinned by an advanced world-wide distribution network, Biosynth provides complete CDMO services at ISO or cGMP and a comprehensive selection of exceptional quality R&D products.
Complete Range of R&D Products
With more than 1 Million research products in their catalog and a global supply network, Biosynth offers outstanding choice, convenience and reliability. Biosynth manufactures and sources the widest range of chemical and biochemical products including carbohydrates, nucleosides, and enzyme substrates along with natural products.
The vast range of Biosynth’s R&D products includes ligands, peptides, phospholipids, antimicrobials and buffers for life sciences, as well as intermediates, building blocks, impurities and coupling reagents for organic chemistry applications.
Chemical Synthesis and CDMO Services
Biosynth offers chemical synthesis and CDMO services for a comprehensive range of bulk and custom chemical and biochemical products.
Biosynth’s knowledge and expertise in the chemistry of carbohydrates, nucleosides, enzyme substrates and intermediates for manufacturing, is truly unrivalled. Whether designing new processes or integrating existing methods for the manufacture of pharmaceutical ingredients or other complex chemicals, Biosynth ensures maximum efficiency and effectiveness.
Biosynth has a flexible end-to-end CDMO service offering, ranging from the transitioning of existing manufacturing and analytical methods ready for GMP manufacturing to a complete chemical process development program of route scouting, optimisation, and analytical development.
With cutting-edge ISO and GMP compliant facilities, Biosynth can manufacture chemicals on scales from milligrams to tons, whilst ensuring optimal budget control and time-to-market. Biosynth can also fill, pack and store products in its temperature-controlled warehouses.
Catalog and Custom Peptides
Biosynth provides an extensive range of high-quality catalog peptides as well as custom peptide manufacturing services that can deliver even the most complex of peptide products.
Biosynth’s Peptide Division provides a complete range of end-to-end peptide manufacturing services, from ready-to-order custom peptide synthesis to lead discovery, optimisation and mg to multikilogram scale and GMP manufacture.
RGD-containing peptides, as well as personalised peptides, can be produced at scale with short turnaround times and maximum flexibility at Biosynth’s high-throughput manufacturing facility.
Along with peptides for screening, discovery and treatment, Biosynth has industry-leading expertise in the manufacture of peptides for neoantigen projects. Biosynth’s experts have also developed a unique technology to discover highly constrained peptides with enhanced affinity, selectivity and proteolytic stability, suited for therapeutic and diagnostic applications, trademarked as CLIPS™.
Key Biological Products & Services
Biosynth provides key biological products and custom projects for antibodies, antigens, plasma, enzymes and epitope mapping.
Offering a wide range of superior antibodies and antigens for in-vitro diagnostic and research applications, the company’s IVD research products include native, viral, bacterial, fungal, and parasitic antigens, as well as a range of recombinant antigens.
The extensive Biosynth catalog of monoclonal antibodies for research also includes a thoughtfully selected range of first-to-market proteins and monoclonal antibodies for new emerging viruses such as Zika, Chikungunya, Dengue and SARs-CoV-2.
Custom Antibody Production and Epitope Mapping
With expert teams dedicated to peptide antigen design and epitope mapping, Biosynth can also support antibody projects.
Biosynth offers outstanding custom polyclonal and monoclonal antibody production, including peptide immunogen and synthesis. Through its ability to synthesise clean and pure peptides, novel design processes, and fully accredited and licensed production plants, Biosynth facilitates the highest probability of success.
Biosynth’s experts pioneered peptide-based epitope mapping, now a fundamental part of therapeutic antibody development. Epitope mapping services for your antibody will provide a functional understanding of the critical residues involved and support regulatory filings and IP protection. Biosynth is also able to support patent applications to further safeguard the competitive interests of customers.
High-performance Enzymes
Biosynth offers a large collection of high-performance enzymes for individual purchase and large-scale manufacturing including innovative lipases, beta-lactamases, peroxidases, phospholipases and other enzymes.
Through the recent acquisition of enzyme manufacturing specialist EUCODIS Bioscience, Biosynth further extended its portfolio to deliver smart enzyme solutions for custom applications and meet its client’s individual biocatalyst requirements. Biosynth’s enzyme development and production team handles the full scope of bioprocess establishment up to the large-scale manufacture of target proteins under ISO9001:2015.
To assist in selecting your ideal enzyme, Biosynth’s experts have developed unique panels of key enzymes used in pharma, cosmetics and chemical applications. The innovative enzyme screening kits offer a wide choice of enzyme variations to screen across target substrates and reaction conditions, including parameters such as activity, selectivity and reaction kinetics.
About Biosynth
Founded in 1966, Biosynth has operated at the edge of innovation for more than half a century, delivering exceptional quality life sciences reagents, chemicals, biologics and custom synthesis and manufacturing services.
Consolidating and stabilising the fragmented pharmaceutical supply chain, Biosynth operates a global network of modern facilities, including sites in Switzerland (HQ), the United Kingdom, Ireland, the Netherlands, Austria, Slovakia, the United States, and China.
For scientists developing ground-breaking medicines and diagnostics, Biosynth’s brand is synonymous with the highest quality products, innovative services and flexible manufacturing approaches.
ProductsChemical Synthesis and CDMO Services
Biosynth specialises in Chemical Synthesis and Contract Development and Manufacturing Organization (CDMO) services, providing a comprehensive range of bulk and custom chemical and biochemical products …
Read MoreChemicals, Peptides and Biochemicals
Biosynth provides an exceptional range of chemicals, peptides and biochemicals, offering scientists and researchers worldwide unparalleled convenience, choice, and dependability. Chemicals & Biochemicals for R&D …
Read MoreDownloadsMonosaccharides Toolbox – Free E-Book – Biosynth
Monosaccharides: ClassificationSources, Modifications, Applications and Analysis A Biosynth .pdf E-Book Monosaccharides Toolbox Authors: Chris Lawson, Ph.D and Hansjorg Streicher, Ph.D …
DownloadVideosInnovative R&D Products and Manufacturing Services – Video – Biosynth
At the Edge of Innovation – Biosynth At the Edge of Innovation – Biosynth, is where Chemistry meets Biology, Products …
Read MorePress ReleasesBiosynth to Exhibit at CPhI Japan 2023
Biosynth, a global leader in Complex Chemicals, Peptides, Biologics with R&D Products and CDMO services, will be exhibiting at CPhI …
Read MoreBiosynth Carbosynth, Vivitide, and Pepscan Unify Under Biosynth Brand
Biosynth Carbosynth, Vivitide, and Pepscan are delighted to announce their new brand identity as Biosynth, in alignment with their parent …
Read MoreBiosynth Carbosynth Acquires EUCODIS Bioscience to offer Enzyme Development
Biosynth Carbosynth, critical materials supplier to the life science industry, has announced the signing of an agreement to acquire EUCODIS …
Read MoreContactBiosynth Ltd
Old Station Business Pk
Compton RG20 6NEUnited Kingdom
Phone: +44 (0)1635 578444
Email: sales@biosynth.com